US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Adcetris 96 MG/100 ML NS IVPB

Reason Lack of Assurance of Sterility

Infusion Options, Inc. D-1746-2019
Class II · Moderate risk Terminated

Abraxane 170 MG / 34 ML IVPB

Reason Lack of Assurance of Sterility

Infusion Options, Inc. D-1745-2019
Class II · Moderate risk Terminated

Robafen DM

Reason CGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Preferred Pharmaceuticals, Inc NDC 68788-0841-01 D-1410-2019
Class II · Moderate risk Terminated

Cetirizine Oral Solution 1 mg/mL

Reason cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

P & L Developments, LLC NDC 11673-178-04 D-1409-2019
Class II · Moderate risk Terminated

Cetirizine Oral Solution 1 mg/mL

Reason cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

P & L Developments, LLC NDC 63868-430-04 D-1408-2019
Class II · Moderate risk Terminated

Cetirizine HCL Oral Solution 1 mg/mL

Reason cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

P & L Developments, LLC NDC 55910-878-04 D-1407-2019
Class II · Moderate risk Terminated

Wal-Fex D Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg

Reason Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit

Sun Pharmaceutical Industries, Inc. D-1390-2019
Class II · Moderate risk Terminated

Wal-Fex D Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg/…

Reason Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit

Sun Pharmaceutical Industries, Inc. D-1389-2019
Class II · Moderate risk Terminated

Allergy Relief D

Reason Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit

Sun Pharmaceutical Industries, Inc. D-1388-2019
Class II · Moderate risk Terminated

Allergy Relief D

Reason Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit

Sun Pharmaceutical Industries, Inc. D-1387-2019
Class II · Moderate risk Terminated

Estradiol Vaginal Inserts USP 10 mcg

Reason Defective Delivery System: Estradiol Vaginal Inserts USP plunger is not functioning properly.

Glenmark Pharmaceuticals Inc., USA NDC 68462-711-71 D-1340-2019
Class II · Moderate risk Terminated

Gericare Geri-Tussin DM

Reason cGMP Deviations: Products may have microbial contamination.

Geritrex, LLC NDC 57896-660-16 D-1526-2019
Class II · Moderate risk Terminated

Ritussin DM Double Strength

Reason cGMP Deviations: Products may have microbial contamination.

Geritrex, LLC D-1525-2019
Class II · Moderate risk Terminated

Ritussin DM Children & Adults

Reason cGMP Deviations: Products may have microbial contamination.

Geritrex, LLC NDC 53807-409-04 D-1521-2019
Class II · Moderate risk Terminated

Diphenhydramine Oral Liquid Alcohol Free

Reason cGMP Deviations: Products may have microbial contamination.

Geritrex, LLC NDC 53807-204-04 D-1520-2019